2005
DOI: 10.1038/sj.onc.1209297
|View full text |Cite
|
Sign up to set email alerts
|

Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas

Abstract: Recently, it was reported that exogenous bone morphogenetic protein (BMP)-2 acted as an antiproliferative agent in a variety of cell lines, including normal and cancerous gastric cell lines, indicating that BMP-2 plays an important role during cell growth. However, despite the loss of BMP-2 expression in several cancers, the underlying mechanism remains unknown. Epigenetic silencing through DNA methylation is one of the key steps during carcinogenesis. In this study, we found, through analysis by the methylati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
64
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 73 publications
(67 citation statements)
references
References 39 publications
3
64
0
Order By: Relevance
“…germ cell-, pluripotencyand developmental-specific genes) that are repressed by CpG island methylation in a tissue-and developmental stage-specific manner (Shen et al 2007, Weber et al 2007, Illingworth et al 2008, Straussman et al 2009). Promoter hypermethylation has been shown to suppress PTGS2 and BMP2 expression in cancer cells (Song et al 2001, Wen et al 2006, suggesting that this chromatin modification may contribute to the suppression of labour-associated inflammatory genes in the gestational tissues during pregnancy. Indeed, we found that variable copy proportions of the studied inflammatory genes were densely methylated in both tissues.…”
Section: Discussionmentioning
confidence: 99%
“…germ cell-, pluripotencyand developmental-specific genes) that are repressed by CpG island methylation in a tissue-and developmental stage-specific manner (Shen et al 2007, Weber et al 2007, Illingworth et al 2008, Straussman et al 2009). Promoter hypermethylation has been shown to suppress PTGS2 and BMP2 expression in cancer cells (Song et al 2001, Wen et al 2006, suggesting that this chromatin modification may contribute to the suppression of labour-associated inflammatory genes in the gestational tissues during pregnancy. Indeed, we found that variable copy proportions of the studied inflammatory genes were densely methylated in both tissues.…”
Section: Discussionmentioning
confidence: 99%
“…All the cell lines were cultured in appropriate medium. For demethylation studies, cells were daily treated with 5 mM 5-aza-2 0 -deoxycytidine (Sigma, St Louis, MO, USA) for 48 h (Wen et al, 2006). A total of 74 primary gastric carcinoma tissue samples and corresponding noncancerous gastric mucosae were obtained as described previously (Wen et al, 2006).…”
Section: Cell Lines and Tissue Samplesmentioning
confidence: 99%
“…Methylation-specific PCR (MSP) and bisulphitesequencing analyses were performed as described previously (Wen et al, 2006). Primer sequences used for all analyses are available upon request.…”
Section: Methylation Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Specifically, restoration of silenced BMP expression could be aimed for to inhibit adrenocortical tumour growth. While hypermethylation of BMP-2 promoter regions has been reported to be the cause of diminished BMP-2 expression in prostate and gastric tumours (Horvath et al 2004, Wen et al 2006, this could not be demonstrated in ACC. However, in vitro treatment of NCIh295R cells with the demethylation agent 5-aza-2 0 -deoxycytidin (5-AZA) was followed by a decrease in BMP-2 promoter methylation, which was further associated with re-expression of endogenous BMPs and activation of downstream IDs ( Johnsen et al 2009).…”
Section: Potential Therapeutic Implicationsmentioning
confidence: 62%